MedTrace Logo

SPG Blocks for Headaches

NCT04255420 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2020-09-03

No results posted yet for this study

Summary

This will be a single-center, open-label clinical trial comparing sphenopalatine ganglion blocks to standard intravenous therapy for patients who come to the emergency department for a headache.

Conditions

Interventions

PROCEDURE

SPG Block

A cotton-tipped applicator soaked in 1% lidocaine will be inserted into the nostril on the side of the headache. If the headache is bilateral, two cotton-tipped applicators will be inserted. The cotton-tipped applicators will be left in place for 15 minutes.

DRUG

Standard IV Treatment

Intravenous prochlorperazine 10 mg plus diphenhydramine 50 mg will be administered.

Sponsors & Collaborators

  • Nova Southeastern University

    collaborator OTHER

  • Kendall Healthcare Group, Ltd.

    lead INDUSTRY

Principal Investigators

  • Tony Zitek, MD · Kendall Healthcare Group, Ltd.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-21
Primary Completion
2021-05-30
Completion
2021-06-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04255420 on ClinicalTrials.gov